September 10, 2020— Five major pharmaceutical companies are flouting the 340B drug pricing program statute, and others appear poised to follow suit. But a vocal group of safety-net providers and national organizations are calling on the federal government to use its authority to put a stop to those actions before patients are harmed. Beginning in late June, the drug makers … [Read more...]
GAO Takes a Closer Look at 340B Contract Pharmacies in New Report
June 29, 2018—Healthcare providers in the 340B drug pricing program pass their savings along to low-income, underinsured patients through drug discounts at their in-house pharmacies or those they contract with, reduced fees at contract pharmacies, or in the form of charity care including free or discounted prescriptions, a new federal report has found. The June 28 Government … [Read more...]